These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 20620182)

  • 1. Carbonate apatite-facilitated intracellularly delivered siRNA for efficient knockdown of functional genes.
    Hossain S; Stanislaus A; Chua MJ; Tada S; Tagawa Y; Chowdhury EH; Akaike T
    J Control Release; 2010 Oct; 147(1):101-8. PubMed ID: 20620182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.
    Spagnou S; Miller AD; Keller M
    Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influences of electrolytes and glucose on formulation of carbonate apatite nanocrystals for efficient gene delivery to mammalian cells.
    Hossain S; Tada S; Akaike T; Chowdhury EH
    Anal Biochem; 2010 Feb; 397(2):156-61. PubMed ID: 19852925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbonate apatite-facilitated intracellular delivery of siRNA.
    Park K
    J Control Release; 2010 Oct; 147(1):1. PubMed ID: 20728485
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuroprotection by biodegradable PAMAM ester (e-PAM-R)-mediated HMGB1 siRNA delivery in primary cortical cultures and in the postischemic brain.
    Kim ID; Lim CM; Kim JB; Nam HY; Nam K; Kim SW; Park JS; Lee JK
    J Control Release; 2010 Mar; 142(3):422-30. PubMed ID: 19944723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
    Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY
    Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective gene suppression using small interfering RNA in hard-to-transfect human T cells.
    Yin J; Ma Z; Selliah N; Shivers DK; Cron RQ; Finkel TH
    J Immunol Methods; 2006 May; 312(1-2):1-11. PubMed ID: 16603179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH-sensitive carbonate apatite as an intracellular protein transporter.
    Tada S; Chowdhury EH; Cho CS; Akaike T
    Biomaterials; 2010 Feb; 31(6):1453-9. PubMed ID: 19854503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug delivery of siRNA therapeutics: potentials and limits of nanosystems.
    Reischl D; Zimmer A
    Nanomedicine; 2009 Mar; 5(1):8-20. PubMed ID: 18640078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection and validation of optimal siRNA target sites for RNAi-mediated gene silencing.
    Luo Q; Kang Q; Song WX; Luu HH; Luo X; An N; Luo J; Deng ZL; Jiang W; Yin H; Chen J; Sharff KA; Tang N; Bennett E; Haydon RC; He TC
    Gene; 2007 Jun; 395(1-2):160-9. PubMed ID: 17449199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery.
    Wang XL; Xu R; Lu ZR
    J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery.
    Golzio M; Mazzolini L; Ledoux A; Paganin A; Izard M; Hellaudais L; Bieth A; Pillaire MJ; Cazaux C; Hoffmann JS; Couderc B; Teissié J
    Gene Ther; 2007 May; 14(9):752-9. PubMed ID: 17344906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
    Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
    Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient and targeted delivery of siRNA in vivo.
    Shim MS; Kwon YJ
    FEBS J; 2010 Dec; 277(23):4814-27. PubMed ID: 21078116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of adeno-associated viral vector for delivery of small interfering RNA.
    Tomar RS; Matta H; Chaudhary PM
    Oncogene; 2003 Aug; 22(36):5712-5. PubMed ID: 12944921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional nanocarrier based on clay nanotubes for efficient intracellular siRNA delivery and gene silencing.
    Wu H; Shi Y; Huang C; Zhang Y; Wu J; Shen H; Jia N
    J Biomater Appl; 2014 Apr; 28(8):1180-9. PubMed ID: 23985535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.
    Akhtar S; Benter I
    Adv Drug Deliv Rev; 2007 Mar; 59(2-3):164-82. PubMed ID: 17481774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound assisted siRNA delivery using PEG-siPlex loaded microbubbles.
    Vandenbroucke RE; Lentacker I; Demeester J; De Smedt SC; Sanders NN
    J Control Release; 2008 Mar; 126(3):265-73. PubMed ID: 18237813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo gene silencing by TransKingdom RNAi (tkRNAi).
    Xiang S; Keates AC; Fruehauf J; Yang Y; Guo H; Nguyen T; Li CJ
    Methods Mol Biol; 2009; 487():147-60. PubMed ID: 19301646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery.
    Cun D; Foged C; Yang M; Frøkjaer S; Nielsen HM
    Int J Pharm; 2010 May; 390(1):70-5. PubMed ID: 19836438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.